“Nvidia’s investment and collaboration with Hippocratic AI marks a significant milestone in our journey to revolutionize healthcare through generative AI,” said Munjal Shah, CEO and Co-Founder of Hippocratic AI. “Our partnership with Nvidia has been instrumental in developing a large language model with extremely low latency, leading to more empathetic and responsive AI healthcare agents. This advancement is crucial in building trust between patients and our AI-driven solutions.”
Shah continued, “The additional funding from Nvidia’s venture capital arm, NVentures, along with other investors, not only validates our approach but also fuels our ongoing research and development efforts. We’re committed to pushing the boundaries of AI in healthcare, focusing on safety, efficacy, and ethical considerations. Our continued research aims to expand the capabilities of our AI agents, exploring new use cases and refining our existing models to address the evolving needs of the healthcare industry.”
“As we move forward, we’re excited about the potential of our AI to help alleviate the global healthcare workforce shortage. Our vision of ‘healthcare abundance’ drives us to innovate continuously, ensuring that our AI can provide high-quality, patient-facing services across various healthcare settings. The support from Nvidia and our other partners empowers us to accelerate our research, particularly in areas such as enhancing the AI’s understanding of medical concepts, improving its ability to engage in natural conversations, and expanding its knowledge base to cover a wider range of healthcare scenarios.”
Read more about the collaboration between Hippocratic AI and NVIDIA by visiting:
NVentures supports Hippocratic AI with funding in extended Series A round